Cancer clinical trials in the region Pays de la Loire
236 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Colon cancer
Rectal cancer
#NCT06662786
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
BRAF
HER2
KRAS G12C
KRAS non G12C
MSI/dMMR
NRAS
Centre Hospitalier Universitaire de Nantes (Nantes)
Janssen
Phase 3
Lung cancer
#NCT06422143
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Metastatic
None
Systemic Treatment-Naive
Immunotherapy
Antibody Drug Conjugates (ADC)
Immunotherapy
Antibody Drug Conjugates (ADC)
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
Merck Sharp & Dohme LLC
Phase 3
Lung cancer
#NCT06635824
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
1
2
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
MET
RET
ROS-1
Systemic Treatment-Naive
Car-T
Hôpital Privé du Confluent - Vivalto Santé (Nantes), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier Universitaire Angers (Angers )
Genmab
Phase 3
CLL & Richter's syndrome
#NCT05947851
CLL (Chronic Lymphocytic Leukemia)
None
Treated / Controled
1
2
3 or more
Systemic Treatment-Naive
Targeted therapy
Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
Merck Sharp & Dohme LLC
Phase 3
Breast cancer
#NCT06435429
HER2 Positive
Locally Advanced
Metastatic
1
2
3 or more
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Centre de Cancerologie de la Sarthe (Le Mans)
Jazz Pharmaceuticals
Phase 3
Kidney cancer
#NCT06364631
Clear cell carcinoma
Metastatic
None
0
1 or 2
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3
Lung cancer
#NCT06472245
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Immunotherapy
ALK
EGFR
ROS-1
Centre Hospitalier de Cholet (Cholet), Centre Hospitalier Universitaire de Nantes (Nantes), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain), Centre Hospitalier du Mans (Le Mans), Centre Hospitalier Départemental de Vendée (La Roche-sur-Yon)
OSE Immunotherapeutics
Phase 3
Lung cancer
#NCT06140836
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
None
1
ALK
BRAF
EGFR
HER2
KRAS G12C
KRAS non G12C
MET
NTRK-1/2/3
RET
PIK3CA
Targeted therapy
Targeted therapy
Centre Hospitalier Universitaire Laennec (Saint-Herblain)
Bristol-Myers Squibb
Phase 3
Lung cancer
#NCT06077760
NSCLC (Non-Small Cell Lung Cancer)
Squamous NSCLC
Non-squamous NSCLC
Localized
Locally Advanced
None
Surgery
Surgery
Immunotherapy
Immunotherapy
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers )
Merck Sharp & Dohme LLC
Phase 3
Liver and bile duct cancer
#NCT05876754
Intrahepatic cholangiocarcinoma
Extrahepatic cholangiocarcinoma
Locally Advanced
Metastatic
IDH1/2
1
2
3 or more
Transplant
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Nantes (Nantes)
Servier